TriangleNCT00496860 · OUTCOME
Clinical Antitumor Response to ALT-801
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- participants
- Interval / dispersion
- Not reported
- Time frame
- 24 months
What was measured
Number of subjects with a complete response (CR), partial response (PR) or stable disease (SD). CR is defined as disappearance of all tumor lesions selected for measurement. PR is defined as at least 30% decrease in the sum of all tumor lesions selected for measurement. Stable disease is defined as neither sufficient tumor shrinkage to qualify for PR nor sufficient tumor increase to qualify for progressive disease (PD) which is defined as at least 20% increase the sum of the all tumor lesions selected for measurement.
Groups in this outcome
ALT-801 0.015 mg/kg/Dose
0.015 mg/kg/dose of ALT-801
ALT-801 0.040 mg/kg/Dose
0.040 mg/kg/dose of ALT-801
ALT-801 0.080 mg/kg/Dose
0.080 mg/kg/dose of ALT-801
| Group | Source count |
|---|---|
| ALT-801 0.015 mg/kg/Dose | 4 |
| ALT-801 0.040 mg/kg/Dose | 16 |
| ALT-801 0.080 mg/kg/Dose | 6 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| ALT-801 0.015 mg/kg/Dose | 2 | Not reported | Not reported | Not reported | Not reported |
| ALT-801 0.040 mg/kg/Dose | 5 | Not reported | Not reported | Not reported | Not reported |
| ALT-801 0.080 mg/kg/Dose | 3 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 2
- group Id
- OG001
- value
- 5
- group Id
- OG002
- value
- 3
- denoms
- counts
- group Id
- OG000
- value
- 4
- group Id
- OG001
- value
- 16
- group Id
- OG002
- value
- 6
- units
- Participants
- description
- Number of subjects with a complete response (CR), partial response (PR) or stable disease (SD). CR is defined as disappearance of all tumor lesions selected for measurement. PR is defined as at least 30% decrease in the sum of all tumor lesions selected for measurement. Stable disease is defined as neither sufficient tumor shrinkage to qualify for PR nor sufficient tumor increase to qualify for progressive disease (PD) which is defined as at least 20% increase the sum of the all tumor lesions selected for measurement.
- groups
- description
- 0.015 mg/kg/dose of ALT-801
- id
- OG000
- title
- ALT-801 0.015 mg/kg/Dose
- description
- 0.040 mg/kg/dose of ALT-801
- id
- OG001
- title
- ALT-801 0.040 mg/kg/Dose
- description
- 0.080 mg/kg/dose of ALT-801
- id
- OG002
- title
- ALT-801 0.080 mg/kg/Dose
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- 24 months
- title
- Clinical Antitumor Response to ALT-801
- type
- SECONDARY
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice